SCHEMBL6426808

SCHEMBL6426808

Cc1c(C(C(=O)O)C2CCC2)c2cc(O)c(F)cc2n1C(=O)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.36
SLC6A3 Q01959 4/20 0.34
MGLL Q99685 3/20 0.34
PGR P06401 2/20 0.34
FAAH O00519 1/20 0.34
SLC6A4 P31645 2/20 0.33
PKM P14618 1/20 0.33
FPR2 P25090 1/20 0.33
PROKR1 Q8TCW9 1/20 0.33
AKR1C3 P42330 1/20 0.32
AKR1C2 P52895 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
AGTR1 P30556 1/20 0.32
SLC6A2 P23975 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6424737 0.98 HSD11B1 (0.37) HSD11B1HPGDTSHRSLC6A3MGLL
SCHEMBL6425963 0.94 PDE2A (0.35) MGLLFAAHAKR1C3AKR1C2
SCHEMBL6423781 0.93 PDE2A (0.35) SLC6A3MGLLFAAHAKR1C3AKR1C2
SCHEMBL6423179 0.91 AKR1C3 (0.41) SLC6A3MGLLAKR1C3AKR1C2LMNA
SCHEMBL6426037 0.90 MEN1 (0.37) HSD11B1MGLLPGRFAAHAKR1C3
SCHEMBL6425613 0.89 AKR1C3 (0.41) MGLLAKR1C3AKR1C2
SCHEMBL6424892 0.89 LMNA (0.34) HSD11B1MGLLFAAHAKR1C3AKR1C2
SCHEMBL6426792 0.89 AKR1C3 (0.37) HSD11B1HPGDMGLLAKR1C3AKR1C2
SCHEMBL6423088 0.88 ALDH1A1 (0.37) HSD11B1MGLLALDH1A1
SCHEMBL6424919 0.88 MEN1 (0.37) HSD11B1MGLLPGRFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 HSD11B1 1120/4885HPGD 15/4885TSHR 3525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.